NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

結核診斷的全球市場:各試驗類型,各類型,各終端用戶的市場調查,預測(∼2025年),COVID-19的累積性的影響

Tuberculosis Diagnostics Market Research Report by Test Type, by Type, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1002728
出版日期 內容資訊 英文 193 Pages
商品交期: 最快1-2個工作天內
價格
結核診斷的全球市場:各試驗類型,各類型,各終端用戶的市場調查,預測(∼2025年),COVID-19的累積性的影響 Tuberculosis Diagnostics Market Research Report by Test Type, by Type, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 193 Pages
簡介

全球結核診斷的市場規模預測將從2020年的25億9,177萬美元,到2025年末達到32億2,308萬美元。

COVID-19是前所未有的全球性公共衛生突發事件,已影響到每個行業。這種長期影響預計將在預測期內影響行業增長。我們正在進行的研究正在擴大我們的研究範圍,以確保我們窮究潛在的COVID-19問題和未來路徑。該報告考慮了消費者行為和需求的變化,購買方式,供應鏈的重新改道,當前市場趨勢以及政府的重要介入等因素,提供有關COVID-19的洞察,分析,與預測。

 

這份報告提供結核診斷的世界市場調查,提供市場概要,市場成長要素及阻礙因素分析,市場機會,COVID-19的影響,試驗類型·類型·終端用戶·各地區的市場規模的變化與預測,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和涵蓋範圍
  • 調查對象涵蓋年份
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 計劃:調查計劃的作成
    • 實行:調查的實施
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 市場預測
  • 試驗類型預測
  • 終端用戶預測
  • 類型預測
  • 地區預測
  • 其他競爭公司預測

第4章 市場概要

  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析
    • 新加入廠商業者的威脅
    • 替代品的威脅
    • 客戶談判力
    • 供給企業談判力
    • 產業的競爭

第6章 各試驗類型

  • 藥物敏感性試驗
  • 實驗室方法
  • Mantoux測試
  • 核酸試驗
  • X光攝影法

第7章 各類型

  • 照護現場技術
  • 迅速試驗

第8章 各終端用戶

  • 診斷調查
  • 醫院和診療所

第9章 南北美洲

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第11章 歐洲,中東·非洲

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第12章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 契約,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獎,獎勵,擴大

第13章 企業的實用性簡介

  • Abbott Laboratories
  • ACON DIABETES CARE
  • Alere, Inc.
  • Becton, Dickinson, and Company
  • BioMerieux SA
  • Boson Biotech Co., Ltd.
  • CapitalBio Technology
  • Cepheid Inc.
  • Elisabeth Pharmacon spol
  • ELITech Group
  • F. Hoffmann-La Roche AG
  • Firstep Bioresearch, Inc.
  • Hain Lifescience GmbH
  • Hologic Corporation
  • Medical Innovation Ventures
  • OSANG Healthcare
  • Oxford Immunotec Ltd.
  • RTA Laboratories
  • Siemens AG
  • Standard Diagnostics
  • Thermo Fisher Scientific, Inc.
  • Turklab Tibbi Malzemeler San

第14章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-03252A5F9275

The Global Tuberculosis Diagnostics Market size was estimated at USD 2,591.77 Million in 2020 and expected to reach USD 2,720.23 Million in 2021, at a Compound Annual Growth Rate (CAGR) 5.29% to reach USD 3,532.13 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Tuberculosis Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Test Type, the Tuberculosis Diagnostics Market was studied across Drug-susceptibility Testing, Laboratory Methods, Mantoux Test, Nucleic Acid Testing, and Radiographic Methods.

Based on Type, the Tuberculosis Diagnostics Market was studied across Point-of-care Technologies and Rapid test.

Based on End_User, the Tuberculosis Diagnostics Market was studied across Diagnostics Research Laboratory and Hospital & Clinics.

Based on Geography, the Tuberculosis Diagnostics Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Tuberculosis Diagnostics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Tuberculosis Diagnostics Market, including Abbott Laboratories, ACON DIABETES CARE, Alere, Inc., Becton, Dickinson, and Company, BioMerieux SA, Boson Biotech Co., Ltd., CapitalBio Technology, Cepheid Inc., Elisabeth Pharmacon spol, ELITech Group, F. Hoffmann-La Roche AG, Firstep Bioresearch, Inc., Hain Lifescience GmbH, Hologic Corporation, Medical Innovation Ventures, OSANG Healthcare, Oxford Immunotec Ltd., RTA Laboratories, Siemens AG, Standard Diagnostics, Thermo Fisher Scientific, Inc., and Turklab Tibbi Malzemeler San.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Tuberculosis Diagnostics Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Tuberculosis Diagnostics Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Tuberculosis Diagnostics Market?
  • 4. What is the competitive strategic window for opportunities in the Global Tuberculosis Diagnostics Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Tuberculosis Diagnostics Market?
  • 6. What is the market share of the leading vendors in the Global Tuberculosis Diagnostics Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Tuberculosis Diagnostics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Test Type Outlook
  • 3.4. End_User Outlook
  • 3.5. Type Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing burden of tuberculosis globally and need to diagnose at very early stage
      • 5.1.1.2. Increasing R&D investments and intensive diagnostics products in pipelines
      • 5.1.1.3. Supportive government initiatives and rising awareness in the emerging markets
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with tuberculosis diagnostics
      • 5.1.2.2. Limited reimbursement options
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising number of government awareness programs
      • 5.1.3.2. Advancement in the diagnostics procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Low coverage or absence of insurance in emerging markets
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Tuberculosis Diagnostics Market, by Test Type

  • 6.1. Introduction
  • 6.2. Drug-susceptibility Testing
  • 6.3. Laboratory Methods
  • 6.4. Mantoux Test
  • 6.5. Nucleic Acid Testing
  • 6.6. Radiographic Methods

7. Tuberculosis Diagnostics Market, by Type

  • 7.1. Introduction
  • 7.2. Point-of-care Technologies
  • 7.3. Rapid test

8. Tuberculosis Diagnostics Market, by End_User

  • 8.1. Introduction
  • 8.2. Diagnostics Research Laboratory
  • 8.3. Hospital & Clinics

9. Americas Tuberculosis Diagnostics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Tuberculosis Diagnostics Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Tuberculosis Diagnostics Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Abbott Laboratories
  • 13.2. ACON DIABETES CARE
  • 13.3. Alere, Inc.
  • 13.4. Becton, Dickinson, and Company
  • 13.5. BioMerieux SA
  • 13.6. Boson Biotech Co., Ltd.
  • 13.7. CapitalBio Technology
  • 13.8. Cepheid Inc.
  • 13.9. Elisabeth Pharmacon spol
  • 13.10. ELITech Group
  • 13.11. F. Hoffmann-La Roche AG
  • 13.12. Firstep Bioresearch, Inc.
  • 13.13. Hain Lifescience GmbH
  • 13.14. Hologic Corporation
  • 13.15. Medical Innovation Ventures
  • 13.16. OSANG Healthcare
  • 13.17. Oxford Immunotec Ltd.
  • 13.18. RTA Laboratories
  • 13.19. Siemens AG
  • 13.20. Standard Diagnostics
  • 13.21. Thermo Fisher Scientific, Inc.
  • 13.22. Turklab Tibbi Malzemeler San

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2026
  • FIGURE 11. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG-SUSCEPTIBILITY TESTING, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG-SUSCEPTIBILITY TESTING, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY LABORATORY METHODS, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY LABORATORY METHODS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MANTOUX TEST, 2018-2026 (USD MILLION)
  • FIGURE 16. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MANTOUX TEST, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2026 (USD MILLION)
  • FIGURE 18. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 19. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY RADIOGRAPHIC METHODS, 2018-2026 (USD MILLION)
  • FIGURE 20. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY RADIOGRAPHIC METHODS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
  • FIGURE 22. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2026
  • FIGURE 24. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE TECHNOLOGIES, 2018-2026 (USD MILLION)
  • FIGURE 25. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE TECHNOLOGIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 26. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2026 (USD MILLION)
  • FIGURE 27. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY RAPID TEST, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 28. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2020 VS 2026 (%)
  • FIGURE 29. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2026
  • FIGURE 31. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS RESEARCH LABORATORY, 2018-2026 (USD MILLION)
  • FIGURE 32. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS RESEARCH LABORATORY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 33. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY HOSPITAL & CLINICS, 2018-2026 (USD MILLION)
  • FIGURE 34. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY HOSPITAL & CLINICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 35. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 36. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 38. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 39. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 40. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. CALIFORNIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. FLORIDA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. ILLINOIS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. NEW YORK TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. OHIO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. PENNSYLVANIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. TEXAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 51. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 53. CHINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. INDIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. INDONESIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. JAPAN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. MALAYSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. PHILIPPINES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. SOUTH KOREA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. THAILAND TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 62. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 63. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 64. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. ITALY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. NETHERLANDS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. QATAR TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 70. SAUDI ARABIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 71. SOUTH AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 72. SPAIN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 73. UNITED ARAB EMIRATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 74. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 75. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 76. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 77. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 78. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG-SUSCEPTIBILITY TESTING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY LABORATORY METHODS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MANTOUX TEST, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY RADIOGRAPHIC METHODS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE TECHNOLOGIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY RAPID TEST, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS RESEARCH LABORATORY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY HOSPITAL & CLINICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. CALIFORNIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. CALIFORNIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. CALIFORNIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. FLORIDA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. FLORIDA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. FLORIDA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. ILLINOIS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. ILLINOIS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. ILLINOIS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. NEW YORK TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. NEW YORK TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. NEW YORK TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. OHIO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. OHIO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. OHIO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. PENNSYLVANIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. PENNSYLVANIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. PENNSYLVANIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. TEXAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. TEXAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. TEXAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. CHINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. CHINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. CHINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. INDIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. INDIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. INDIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. INDONESIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. INDONESIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. INDONESIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. JAPAN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. JAPAN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. JAPAN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. MALAYSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. MALAYSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. MALAYSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. PHILIPPINES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. PHILIPPINES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. PHILIPPINES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. SOUTH KOREA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. SOUTH KOREA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. SOUTH KOREA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. THAILAND TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. THAILAND TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. THAILAND TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. ITALY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. ITALY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. ITALY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. NETHERLANDS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. NETHERLANDS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. NETHERLANDS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. QATAR TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. QATAR TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. QATAR TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. SAUDI ARABIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. SAUDI ARABIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. SAUDI ARABIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. SOUTH AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. SOUTH AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. SOUTH AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. SPAIN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. SPAIN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. SPAIN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. UNITED ARAB EMIRATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. UNITED ARAB EMIRATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. UNITED ARAB EMIRATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: SCORES
  • TABLE 122. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: BUSINESS STRATEGY
  • TABLE 123. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: PRODUCT SATISFACTION
  • TABLE 124. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: RANKING
  • TABLE 125. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 126. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: SHARE, BY COMPANY, 2020
  • TABLE 127. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: MERGER & ACQUISITION
  • TABLE 128. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 129. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 130. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: INVESTMENT & FUNDING
  • TABLE 131. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 132. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: LICENSE & PRICING
  • TABLE 133. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: CONTACT DETAILS